Close

European Commission Clears Acquisition of Gensyme Corporation by sanofi-aventis

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Sanofi-aventis announced that the European Commission has cleared sanofi-aventis’ proposed acquistion of Genzyme corporation unconditionally under EU merger control rules. Sanofi-aventis welcomes this decision, which is a requisite step in satisfaction of the condition to the tender offer relating to antitrust approvals.

The offer remains subject to the other conditions described in the offer to purchase filled with the U.S. Securities and Exchance Commission on October 4, 2010, as amended to date.

Latest stories

Previous article

Shionogi Inc announced availabilty of Kapvay

Next article

Boehringer Ingelheim to Purchase Amgen’s Fremont Facility

Related stories

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

MORE STORIES